Title : Approaches to the treatment of patients with hormone-sensitive prostate cancer.

Pub. Date : 1999 Oct

PMID : 10604265






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Of several agents recently shown to reduce prostate-specific antigen levels in phase II studies, 13-cis-retinoic acid and interferon-alpha can reduce the expression of bcl-2 and overcome bcl-2-mediated resistance to paclitaxel in resistant cell lines. Isotretinoin kallikrein related peptidase 3 Homo sapiens